IPCA LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,306 INR | +0.29% |
|
+1.45% | +17.34% |
| 03-29 | Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director | CI |
| 03-29 | Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director | CI |
Presentation Operator MessageOperator (Operator)Thank you. Good afternoon, everyone, and a ver...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIâs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.
Sector
Pharmaceuticals
Calendar
2024-05-28
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
1,307
INR
Average target price
1,163
INR
Spread / Average Target
-11.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +37.78% | 705B | |
| +32.82% | 583B | |
| -3.51% | 364B | |
| +19.94% | 332B | |
| +5.14% | 291B | |
| +16.64% | 238B | |
| -4.13% | 210B | |
| +10.63% | 209B | |
| +9.32% | 169B |
- Stock Market
- Equities
- IPCALAB Stock
- IPCALAB Stock
- News Ipca Laboratories Limited
- Transcript : Ipca Laboratories Limited, Q2 2023 Earnings Call, Nov 14, 2022
